Any current/future new fundraising through debt or equity?

Currently, there are no plans for new CAPEX or fundraising through debt or equity. The company has recently expanded using debt and internal accruals. There was a mention of a future Follow-on Public Offer (FPO), but it is currently on hold. No additional debt or equity raising is planned at this moment.

Any current/future capex/capital investment/strategic investment?

Currently, there are no immediate plans for new capital expenditure (capex) or expansions. The company has already completed expansions in the last one and a half years using a mix of debt and internal accruals. A proposed Follow-on Public Offer (FPO) intended to raise capital is currently on hold. The focus remains on utilizing existing capacities effectively rather than committing to fresh large-scale investments in the near term.

Future growth expectations in sales/revenue/volumes?

Demand outlook is optimistic from Q4 FY23 and into FY24, with inquiries increasing significantly since January. Growth is expected to be better than FY22 and FY23, driven by improving demand in India and export markets. Expansion in chemical, pharmaceutical, agrochemical sectors is expected to boost growth. Exports, especially in hospital furniture segment, show promise with growing inquiries but no current exports. New client addition: 25-30 new clients added in last 6 months, mainly in plastic packaging. Capacity utilization currently at around 65%, with scope for improvement as demand picks

Future growth expectations in earnings/operating earnings/profits/EPS?

The management is optimistic about FY24, expecting much better performance than FY22 and FY23. Demand outlook from January 2023 is picking up strongly with increased inquiries converting into business. Positive growth seen across sectors with better utilization expected in Q4 FY23 and beyond. Repeat business is strong, with 80% revenue from about 50 clients, many being Fortune 500 companies, indicating stable earnings. EBITDA margins expected to improve sequentially from Q4 FY23 as high-cost inventory gets exhausted. Expansion plans on hold currently, but internal accruals and debt financing h

Current/ Expected Orderbook/ Pending Orders?

The company has added around 25 to 30 new clients in the last 6 months, indicating a growing order book. Approximately 80% of the business comes from about 50 companies, with 45 to 50 companies providing repeat orders annually, showing a stable and recurring order flow. Inquiry levels have picked up significantly from January, translating into many new inquiries and potential converts into business. New orders are notably from plastic packaging, hospital furniture segments, and emerging export markets. The company is optimistic about onboarding many more clients going forward. No specific info

Mitsu Chem Plast LtdQ3 FY23Industrial Products

Mitsu Chem Plast Ltd Q3 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹178P/E: 10.5Market Cap: ₹243 CrSector: Industrial Products

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

Order

Yes

Capex

1 of 5 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Demand outlook is optimistic from Q4 FY23 and into FY24, with inquiries increasing significantly since January.
Growth is expected to be better than FY22 and FY23, driven by improving demand in India and export markets.
Expansion in chemical, pharmaceutical, agrochemical sectors is expected to boost growth.
Exports, especially in hospital furniture segment, show promise with growing inquiries but no current exports.
New client addition: 25-30 new clients added in last 6 months, mainly in plastic packaging.
Capacity utilization currently at around 65%, with scope for improvement as demand picks up.
Company is optimistic about entering sustainable packaging and recycling initiatives, which may spur future growth.
Expected sequential improvement in margins from Q4 due to normalization of polymer prices and better product mix.
Capital expenditure plans are on hold currently; expansion done in last 1.5 years funded through debt and internal accruals.

Margin guidance

Category 2

The management is optimistic about FY24, expecting much better performance than FY22 and FY23.
Demand outlook from January 2023 is picking up strongly with increased inquiries converting into business.
Positive growth seen across sectors with better utilization expected in Q4 FY23 and beyond.
Repeat business is strong, with 80% revenue from about 50 clients, many being Fortune 500 companies, indicating stable earnings.
EBITDA margins expected to improve sequentially from Q4 FY23 as high-cost inventory gets exhausted.
Expansion plans on hold currently, but internal accruals and debt financing have supported past expansions.
Growth drivers include increasing demand in plastic packaging, hospital furniture, and new technical products.
Focus on sustainability and innovative products aims to enhance product mix and profitability.
Overall outlook for FY24 and FY25 is bullish with expected significant improvement in top-line and profitability.

See what Mitsu Chem Plast Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Currently, there are no plans for new CAPEX or fundraising through debt or equity.
The company has recently expanded using debt and internal accruals.
There was a mention of a future Follow-on Public Offer (FPO), but it is currently on hold.
No additional debt or equity raising is planned at this moment.

Order book

Yes

The company has added around 25 to 30 new clients in the last 6 months, indicating a growing order book.
Approximately 80% of the business comes from about 50 companies, with 45 to 50 companies providing repeat orders annually, showing a stable and recurring order flow.
Inquiry levels have picked up significantly from January, translating into many new inquiries and potential converts into business.
New orders are notably from plastic packaging, hospital furniture segments, and emerging export markets.
The company is optimistic about onboarding many more clients going forward.
No specific information on the total value or backlog of pending orders was disclosed, but improvement in inquiries and customer additions point to a positive order pipeline.

See what Mitsu Chem Plast Ltd management said on order book — free account, 30 seconds.

Capex plans

Currently, there are no immediate plans for new capital expenditure (capex) or expansions.
The company has already completed expansions in the last one and a half years using a mix of debt and internal accruals.
A proposed Follow-on Public Offer (FPO) intended to raise capital is currently on hold.
The focus remains on utilizing existing capacities effectively rather than committing to fresh large-scale investments in the near term.

Track Mitsu Chem Plast Ltd — get its next earnings analysis in your feed

How does Mitsu Chem Plast Ltd rank vs peers in Industrial Products?

Pro feature

ThisMitsu Chem Plast Ltd

Rev 3Mar 2

See where Mitsu Chem Plast Ltd sits in Industrial ProductsSee which companies these are, and every other name in the sector.Open rankings

How does Mitsu Chem Plast Ltd rank in Industrial Products?

Compare Mitsu Chem Plast Ltd against every Industrial Products company (Q3 FY23) on revenue, margins and earnings-call signals.

View Industrial Products leaderboard →

What Mitsu Chem Plast Ltd's management said in earlier quarters

Others in Industrial Products this season

Monolithisch India Ltd (Q2 FY27)
Combined additional capacity: 3 lakh MT per annum; total capex approximately INR 45 crores. Key concall takeaways from Monolithisch India Ltd's Q2 FY27…
Systematic Industries Ltd (Q1 FY27)
Year-on-Year (YoY) Growth for Q4 Net Sales:** 6.0% . Key concall takeaways from Systematic Industries Ltd's Q1 FY27 earnings call — and how it ranks against…
Graphite India Ltd (Q3 FY24)
690 crore, down 1.6% y-o-y (Page 5, 9) . Key concall takeaways from Graphite India Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.
Graphite India Ltd (Q4 FY24)
720 Cr, down 11.7% y-o-y (Page 4, 9) . Key concall takeaways from Graphite India Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.

Compare:vs Polycab India Ltd vs Welspun Corp Ltd vs APL Apollo Tubes

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →